$RARX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ra Pharmaceuticals, Inc.. Get notifications about new insider transactions in Ra Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Lettmann Jason | Director | Buy | X | 0.07 | 63,019 | 4,411 | 80,161 | 17.1 K to 80.2 K (+367.63 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | MOTT DAVID M | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 3,402,729 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 3,657,932 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 9,728,589 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | X | 0.07 | 62,914 | 4,404 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 13.00 | 84,615 | 1,099,995 | 2,545,652 | 2.5 M to 2.5 M (+3.44 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 486,104 | 0 | 2,461,037 | 2 M to 2.5 M (+24.61 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 522,561 | 0 | 1,974,933 | 1.5 M to 2 M (+35.98 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 1,389,797 | 0 | 1,452,372 | 62.6 K to 1.5 M (+2,221.01 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 13.00 | 339 | 4,407 | 62,575 | 62.9 K to 62.6 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Buy | X | 0.07 | 62,914 | 4,404 | 62,914 | 0 to 62.9 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | KERINS PATRICK J | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BASKETT FOREST | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRIS PETER J | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | BARRETT M JAMES | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |